Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance

About this update from Masimo Corporation

[{"type":"text","content":"\nComplete fourth quarter and full-year 2023 financial results will be announced on Tuesday, February 27, 2024\n\n\n IRVINE, California--(BUSINESS WIRE)--\nMasimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 30, 2023 and provided estimates for its full-year 2024 guidance.\n\n\nPreliminary Fourth Quarter 2023 Financial Results:\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nConsolidated revenue of $541 million to $551 million;\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nHealthcare revenue of $336 million to $341 million; and\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-healthcare revenue of $205 million to $210 million.\n\n\n\n\n\n\n\nPreliminary Full-Year 2023 Financial Results:\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nConsolidated revenue of $2,041 million to $2,051 million;\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nHealthcare revenue of $1,272 million to $1,277 million; and\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-healthcare revenue of $769 million to $774 million.\n\n\n\n\n\n\n\nThe preliminary financial information presented in this press release is based on Masimo’s current expectations and may be adjusted as a result of, among other things, completion of customary annual audit procedures. Management plans to discuss Masimo’s complete fourth quarter and full-year 2023 financial results after the market closes on Tuesday, February 27, 2024.\n\n\nFull-Year 2024 Guidance:\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nConsolidated revenue of $2,045 million to $2,165 million;\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nHealthcare revenue of $1,345 million to $1,385 million;\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-healthcare revenue of $700 million to $780 million;\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nGAAP earnings per diluted share of $1.91 to $2.08;\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-GAAP earnings per diluted share of $3.00 to $3.15 (prior definition); and\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n•\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-GAAP earnings per diluted share of $3.44 to $3.60 (updated definition).\n\n\n\n\n\n\n\nEffective fiscal year 2024, ...

More updates from Masimo Corporation